drugset / Trial / NCT06974656

Infusion of Dexmedetomidine Versus Lidocaine in Management of Acute Postoperative Pain After Modified Radical Mastectomy

NCT06974656 ↗

Completed 40 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to compare the effect of intraoperative intravenous infusion of dexmedetomidine and lidocaine in the management of acute postoperative pain after mastectomy.

Timeline

Start
2025-05-15
Primary completion
2025-08-20
Completion
2025-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.